SCHEMBL23367178

SCHEMBL23367178

CCOC(=O)C(/C=N/O)=N/Nc1ccc(F)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.58
MEN1 O00255 6/20 0.58
KMT2A Q03164 6/20 0.58
L3MBTL1 Q9Y468 2/20 0.58
HTT P42858 1/20 0.58
GAA P10253 4/20 0.50
KDM4E B2RXH2 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
THRB P10828 1/20 0.49
ALOX12 P18054 1/20 0.49
ALDH1A1 P00352 3/20 0.49
LMNA P02545 5/20 0.48
NPSR1 Q6W5P4 3/20 0.48
GFER P55789 1/20 0.48
CYP1A2 P05177 2/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
MAPK1 P28482 1/20 0.46
KYAT1 Q16773 5/20 0.44
ATM Q13315 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23354670 1.00 MAPT (0.58) MAPTMEN1KMT2AL3MBTL1HTT
SCHEMBL23354669 1.00 MAPT (0.58) MAPTMEN1KMT2AL3MBTL1HTT
SCHEMBL29874081 0.95 MAPT (0.54) MAPTMEN1KMT2AL3MBTL1HTT
SCHEMBL23354840 0.89 KYAT1 (0.54) MAPTMEN1KMT2AL3MBTL1HTT
SCHEMBL23384676 0.89 KYAT1 (0.54) MAPTMEN1KMT2AL3MBTL1HTT
SCHEMBL23354842 0.89 KYAT1 (0.54) MAPTMEN1KMT2AL3MBTL1HTT
SCHEMBL23367553 0.87 MEN1 (0.57) MAPTMEN1KMT2AL3MBTL1HTT
SCHEMBL23354968 0.87 MEN1 (0.57) MAPTMEN1KMT2AL3MBTL1HTT
SCHEMBL23367424 0.87 KYAT1 (0.56) MAPTMEN1KMT2AL3MBTL1HTT
SCHEMBL23367177 0.86 MAPT (0.55) MAPTMEN1KMT2AL3MBTL1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230027985-A1 SUBSTITUTED HYDANTOINAMIDES AS ADAMTS7 ANTAGONISTS BAYER AKTIENGESELLSCHAFT (DE) 2023-01-26 US disclosed
WO-2021094434-A1 SUBSTITUTED HYDANTOINAMIDES AS ADAMTS7 ANTAGONISTS BAYER AKTIENGESELLSCHAFT (DE) 2021-05-20 WO disclosed
EP-3822265-A1 SUBSTITUTED HYDANTOINAMIDES AS ADAMTS7 ANTAGONISTS Bayer AG (DE) 2021-05-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230027985-A1 SUBSTITUTED HYDANTOINAMIDES AS ADAMTS7 ANTAGONISTS ADAMTS7, MMP7, ADAMTS1 MAPT 4378/4885MEN1 2636/4885KMT2A 3100/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.